We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Recall of Thousands of MRI Scanners Issued by US FDA

By MedImaging International staff writers
Posted on 23 Feb 2015
The United States (US) Food and Drug Administration (FDA) has issued a Class 1 Recall notice for a large number of GE Healthcare (Chalfont St. Giles, Buckinghamshire, UK) Magnetic Resonance Imaging (MRI) systems. All MRI systems using superconducting magnets, manufactured from 1985 to the present are affected. The notice was dated February 18th, 2015.

Already on January 6, 2015, GE Healthcare had sent an "Urgent Medical Device Correction" letter to hospital administrators/risk managers, radiology department managers, and radiologists, in the US and around the world. The letter described the safety issue, safety instructions, affected product details, product correction and contact information. The letter was necessary when GE Healthcare discovered that the Magnet Rundown Units (MRU) on its imaging devices may not be properly connected.

To correct the issue, GE Healthcare has instructed customers to perform preventative measures to confirm that the MRU is connected to the magnet. The measures consist of a four-step test on the MRU. The steps are explained on the GE Healthcare and FDA websites.

According the FDA recall notice, “In emergency situations, a disconnected MRU could delay removal of a ferrous object from the magnet, potentially resulting in life-threatening injuries.”

Related Links:

GE Healthcare
US Food and Drug Administration (FDA)


Ultrasound Needle Guidance System
SonoSite L25
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Biopsy Software
Affirm® Contrast
Digital Radiographic System
OMNERA 300M

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.